Holen Sie sich die Stockscreener-App
13.88
5.23%
0.69
Schlusskurs vom Vortag:
$13.19
Offen:
$13.59
24-Stunden-Volumen:
1.24M
Relative Volume:
1.24
Marktkapitalisierung:
$618.52M
Einnahmen:
$110.24M
Nettoeinkommen (Verlust:
$-66.44M
KGV:
-9.1854
EPS:
-1.5111
Netto-Cashflow:
$-61.12M
1W Leistung:
-5.51%
1M Leistung:
+47.66%
6M Leistung:
-52.24%
1J Leistung:
-21.93%
1-Tages-Spanne:
$13.21
$13.95
1-Wochen-Bereich:
$13.17
$15.00
52-Wochen-Spanne:
$8.80
$32.71
Beta Bionics Inc Stock (BBNX) Company Profile
Firmenname
Beta Bionics Inc
Sektor
Branche
Telefon
949-427-7785
Adresse
11 HUGHES, IRVINE
Compare BBNX vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
13.88 | 618.52M | 110.24M | -66.44M | -61.12M | -1.5111 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-09 | Eingeleitet | UBS | Buy |
| 2026-01-27 | Eingeleitet | TD Cowen | Hold |
| 2026-01-09 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-10-21 | Fortgesetzt | Stifel | Buy |
| 2025-10-01 | Hochstufung | Goldman | Neutral → Buy |
| 2025-06-16 | Eingeleitet | Truist | Buy |
| 2025-06-12 | Eingeleitet | Lake Street | Buy |
| 2025-05-30 | Eingeleitet | Goldman | Neutral |
| 2025-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2025-02-24 | Eingeleitet | BofA Securities | Buy |
| 2025-02-24 | Eingeleitet | Lake Street | Buy |
| 2025-02-24 | Eingeleitet | Leerink Partners | Outperform |
| 2025-02-24 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-24 | Eingeleitet | Stifel | Buy |
| 2025-02-20 | Eingeleitet | Ladenburg Thalmann | Neutral |
| 2025-02-20 | Eingeleitet | Robert W. Baird | Neutral |
Alle ansehen
Beta Bionics Inc Aktie (BBNX) Neueste Nachrichten
Beta Bionics Inc (BBNX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Beta Bionics Inc (BBNX) Institutional Confidence - TradingKey
Beta Bionics Inc (BBNX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Beta Bionics Inc (BBNX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Beta Bionics Inc (BBNX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Beta Bionics Inc (BBNX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growth - TradingView
Beta Bionics (BBNX) Securities Investigation: Johnson - GlobeNewswire
Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Rev - GuruFocus
BBNX Q1 2026 Earnings: Narrower-Than-Expected Loss and Steady Progress in Diabetes TechnologyEarnings Momentum Score - newsline.com
Insider Sell: Mark Hopman Sells Shares of Beta Bionics Inc (BBNX) - GuruFocus
Beta bionics CCO Mark Hopman sells $3,385 in shares By Investing.com - Investing.com South Africa
Beta bionics CCO Mark Hopman sells $3,385 in shares - Investing.com UK
Beta Bionics | 4: Statement of changes in beneficial ownership of securities-Officer Hopman Mark - Moomoo
Beta Bionics | 4: Statement of changes in beneficial ownership of securities-Director Jones Christy - Moomoo
Beta bionics director Jones Christy sells $39,354 in stock - Investing.com UK
Beta bionics director Jones Christy sells $39,354 in stock By Investing.com - Investing.com South Africa
Robbins LLP Reminds BBNX Stockholders of its Investigation into Beta Bionics, Inc.; Contact the Firm for Information - GlobeNewswire
Robbins LLP Reminds BBNX Stockholders of its Investigation into Beta Bionics, Inc.; Contact the Firm for Information - GlobeNewswire Inc.
Beta Bionics (BBNX) CCO logs small 275-share sale under Rule 10b5-1 plan - Stock Titan
Beta Bionics (NASDAQ: BBNX) director sells 2,811 shares in planned trade - Stock Titan
Have Beta Bionics Insiders Been Selling Stock? - simplywall.st
BBNX Q1 2026 Earnings: Narrower Loss Surprises, Stock Jumps 11.57%Investor Earnings Call - newsline.com
Beta Bionics | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
BBNX Investor Notice: Robbins LLP Reminds Beta Bionics, Inc. That it is Investigating The Company's Officers and Directors to Determine if They Violated Securities Laws and Breached Fiduciary Duties to Shareholders - ACCESS Newswire
Christina Jones to sell 2,811 BBNX shares (NASDAQ: BBNX) under 10b5-1 - Stock Titan
Beta Bionics, Inc. Common Stock (NASDAQ: BBNX) Stock Price, News & Analysis - Kalkine
BBNX (NASDAQ: BBNX) affiliate files Rule 144 to sell 275 shares - Stock Titan
Beta Bionics, Inc. (BBNX) Investigation: Johnson Fistel - GlobeNewswire
Beta bionics CPO Mike Mensinger sells $55,193 in stock By Investing.com - Investing.com India
Beta bionics CPO Mike Mensinger sells $55,193 in stock - Investing.com
Beta Bionics (BBNX) CPO sells 4,378 shares to cover RSU tax withholding - Stock Titan
Beta Bionics (NASDAQ: BBNX) CCO sells 5,329 shares to cover RSU taxes - Stock Titan
Beta Bionics (BBNX) CMO sells 4,222 shares to cover tax obligations - Stock Titan
Beta Bionics (BBNX) CFO sells 6,676 shares to cover RSU tax obligations - Stock Titan
Beta Bionics (NASDAQ: BBNX) CEO sells 16,872 shares to cover RSU taxes - Stock Titan
BBNX (NASDAQ) director/resignee plans resale of RSUs vesting 06/01/2026 - Stock Titan
BBNX (NASDAQ) Form 144: 4,222 vested RSU shares via Morgan Stanley - Stock Titan
Insider sale filing: Beta Bionics (NASDAQ: BBNX) proposes 4,378-share sale - Stock Titan
6,676 RSUs vest; BBNX (NASDAQ: BBNX) Form 144 notes prior 1,428-share sale - Stock Titan
BBNX (NASDAQ: BBNX) affiliate notifies planned sale of 16,872 shares via broker - Stock Titan
Beta Bionics, Inc. Securities Fraud Investigation – Robbins - GlobeNewswire
Beta Bionics Investors Suffer Significant Losses After Company Re - The National Law Review
Beta Bionics Investors Suffer Significant Losses After Company Reports Slower New Patient Start Growth; Contact Johnson Fistel - Business Wire
Beta Bionics Under Investigation for Securities Violations - Intellectia AI
BBNX Shareholder Alert: Robbins LLP Reminds Beta Bionics, - GlobeNewswire
Beta Bionics Publishes Near Real-Time Real-World Data Dashboard for the Ilet Bionic Pancreas - marketscreener.com
BBNX Shareholder Alert: Robbins LLP Reminds Beta Bionics, Inc. S - GuruFocus
Beta Bionics Investors Who Suffered Losses May Be Eligible for Recovery-Learn More Today, Contact Johnson Fistel - marketscreener.com
Beta Bionics launches real-time data dashboard for iLet device - Investing.com
Beta Bionics launches real-time data dashboard for iLet device By Investing.com - Investing.com Australia
Finanzdaten der Beta Bionics Inc-Aktie (BBNX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):